Men in the US and Canada concerned about persistent sexual side effects "coined the phrase 'post finasteride syndrome', which they say is characterized by sexual, neurological, hormonal and psychological side effects that can persist in men who have taken finasteride for hair loss or an enlarged prostate".   In 2012, a health advocacy group called the Post-Finasteride Syndrome Foundation was formed with the primary goal of finding a cure for the reported syndrome and a secondary goal of raising awareness.  According to the company's 1Q2016 financial filing, Merck is a defendant in 1,385 product liability lawsuits which have been filed by customers alleging they have experienced persistent sexual side effects following cessation of treatment with finasteride. 
He said that he had never heard of a therapeutic-use exemption (TUE), which athletes who are taking certain substances would require to not be deemed in violation of anti-doping rules if they test positive for a prohibited substance. He said that he had never visited JADCO's website to make himself familiar with the responsibilities of an athlete as it relates to substances found within his or her system; he had never tried to educate himself on JADCO's rules; and he added that January 2017 was the first time in his five years as a professional athlete that he knew of the prohibited list regarding certain medications. While he admitted receiving pamphlets from JADCO, Livermore added that he had only read the ones that included the list of prohibited substances.